Is fludeoxyglucose-fluorodeoxyglucose-positron emission tomography/computed tomography ((18)F-FDG-PET/CT) really useless in staging pulmonary carcinoid tumors and in discriminating histological subtypes? Controversial points and future perspectives.
作者信息
Lococo Filippo, Stefani Alessandro, Treglia Giorgio
机构信息
Unit of Thoracic Surgery, IRCCS-Arcispedale Santa Maria Nuova, Reggio Emilia, Italy E-mail:
Unit of Thoracic Surgery, University of Modena, Modena, Italy.
出版信息
Ann Thorac Med. 2015 Jul-Sep;10(3):217-8. doi: 10.4103/1817-1737.157292.
Abstract
摘要
相似文献
1
Is fludeoxyglucose-fluorodeoxyglucose-positron emission tomography/computed tomography ((18)F-FDG-PET/CT) really useless in staging pulmonary carcinoid tumors and in discriminating histological subtypes? Controversial points and future perspectives.
Ann Thorac Med. 2015 Jul-Sep;10(3):217-8. doi: 10.4103/1817-1737.157292.
2
Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
Q J Nucl Med Mol Imaging. 2015 Dec;59(4):446-54.
3
Whole-body F-fluorodeoxyglucose positron emission tomography-computed tomography (F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
Indian J Med Res. 2018 Mar;147(3):256-262. doi: 10.4103/ijmr.IJMR_1368_16.
4
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
J Intern Med. 2006 Dec;260(6):545-50. doi: 10.1111/j.1365-2796.2006.01729.x.
5
Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
Nucl Med Commun. 2019 May;40(5):517-524. doi: 10.1097/MNM.0000000000000985.
6
Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
World J Nucl Med. 2015 Jan-Apr;14(1):19-24. doi: 10.4103/1450-1147.150519.
7
Role of F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer Patients.
Thyroid. 2019 Apr;29(4):549-556. doi: 10.1089/thy.2018.0552.
8
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218.
9
Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors.
Surg Today. 2019 Jan;49(1):21-26. doi: 10.1007/s00595-018-1703-2. Epub 2018 Aug 20.
10
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13.
引用本文的文献
1
Current Applications for Nuclear Medicine Imaging in Pulmonary Disease.
Curr Pulmonol Rep. 2020;9(3):82-95. doi: 10.1007/s13665-020-00251-1. Epub 2020 Jul 22.
2
Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system.
Clin Transl Oncol. 2018 May;20(5):670-677. doi: 10.1007/s12094-017-1759-2. Epub 2017 Oct 11.
本文引用的文献
1
18F-FDG PET/CT rarely provides additional information other than primary tumor detection in patients with pulmonary carcinoid tumors.
Ann Thorac Med. 2014 Oct;9(4):227-31. doi: 10.4103/1817-1737.140134.
2
Functional imaging evaluation in the detection, diagnosis, and histologic differentiation of pulmonary neuroendocrine tumors.
Thorac Surg Clin. 2014 Aug;24(3):285-92. doi: 10.1016/j.thorsurg.2014.04.004. Epub 2014 Jun 6.
3
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.
Tumour Biol. 2014 Sep;35(9):8369-77. doi: 10.1007/s13277-014-2102-y. Epub 2014 May 22.
4
Evolving role of PET/CT with different tracers in the evaluation of pulmonary neuroendocrine tumours.
Eur J Nucl Med Mol Imaging. 2014 May;41(5):853-5. doi: 10.1007/s00259-014-2695-9. Epub 2014 Feb 21.
5
Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.
J Cardiothorac Surg. 2013 Dec 4;8:223. doi: 10.1186/1749-8090-8-223.
6
Neuroendocrine tumors of the lung: an update.
Arch Pathol Lab Med. 2010 Nov;134(11):1628-38. doi: 10.5858/2009-0583-RAR.1.
Zotero 插件